Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas

Gastroenterology Research and Practice

Volumn , Issue , 2009, Pages

  Aamodt, Rolf ^a,b   Jonsdottir, Kristin ^b   Andersen, Solveig Norheim ^a,b   Bondi, Johan ^b   Bukholm, Geir ^b   Bukholm, Ida R K ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN A2; CYCLIN B1; CYCLIN D1; CYCLIN D3; CYCLIN E; CYCLINE; MYC PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; COLON ADENOCARCINOMA; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; RECTUM CARCINOMA; RECURRENCE RISK;

EID: 73549088535     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2009/285830     Document Type: Article

References (62)

1. Aamodt R., Bondi J., Andersen S. N., Bukholm G., Bukholm I. R. K., Expression of nuclear beta-catenin in rectal versus colonic cancers The Open Clinical Cancer Journal 2008 2 13 17
2. Sherr C. J., G1 phase progression: cycling on cue Cell 1994 79 4 551 555
3. Assoian R. K., Zhu X., Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression Current Opinion in Cell Biology 1997 9 1 93 98
4. Ohtsubo M., Theodoras A. M., Schumacher J., Roberts J. M., Pagano M., Human cyclin E, a nuclear protein essential for the G1-to-S phase transition Molecular Cellular Biology 1995 15 5 2612 2624
5. Girard F., Strausfeld U., Fernandez A., Lamb N. J. C., Cyclin A is required for the onset of DNA replication in mammalian fibroblasts Cell 1991 67 6 1169 1179
6. Walker D. H., Maller J. L., Role for cyclin A in the dependence of mitosis on completion of DNA replication Nature 1991 354 6351 314 317
7. Pagano M., Pepperkok R., Verde F., Ansorge W., Draetta G., Cyclin A is required at two points in the human cell cycle EMBO Journal 1992 11 3 961 971
8. King R. W., Jackson P. K., Kirschner M. W., Mitosis in transition Cell 1994 79 4 563 571
9. Arellano M., Moreno S., Regulation of CDK/cyclin complexes during the cell cycle International Journal of Biochemistry and Cell Biology 1997 29 4 559 573
10. Nilbert M., Rambech E., β-catenin activation through mutation is rare in rectal cancer Cancer Genetics Cytogenetics 2001 128 1 43 45
11. Polakis P., Wnt signaling and cancer Genes Development 2000 14 15 1837 1851
12. Kimura Y., Shiozaki H., Doki Y., Cytoplasmic -catenin in esophageal cancers International Journal of Cancer 1999 84 2 174 178
13. Morin P. J., Sparks A. B., Korinek V., Activation of -catenin-Tcf signaling in colon cancer by mutations in -catenin or APC Science 1997 275 5307 1787 1790 (Pubitemid 27136715)
14. Munemitsu S., Albert I., Souza B., Rubinfeld D., Polakis P., Regulation of intracellular -catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein Proceedings of the National Academy of Sciences of the United States of America 1995 92 7 3046 3050
15. Dang C. V., c-Myc target genes involved in cell growth, apoptosis, and metabolism Molecular Cellular Biology 1999 19 1 1 11
16. Nesbit C. E., Tersak J. M., Prochownik E. V., MYC oncogenes and human neoplastic disease Oncogene 1999 18 19 3004 3016
17. Rothberg P. G., The role of the oncogene c-Myc in sporadic large bowel cancer and familial polyposis coli Seminars in Surgical Oncology 1987 3 3 152 158
18. Prochownik E. V., c-Myc as a therapeutics target in cancer Expert Review of Anticancer Therapy 2004 4 2 289 302
19. Bondi J., Bukholm G., Nesland J. M., Bukholm I. R. K., Expression of non-membranous -catenin and -catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas Acta Pathologica, Microbiologica et Immunologica Scandinavica 2004 112 1 49 56
20. Bondi J., Husdal A., Bukholm G., Nesland J. M., Bakka A., Bukholm I. R. K., Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome Journal of Clinical Pathology 2005 58 5 509 514
21. Rudolph P., Kuhling H., Alm P., Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer International Journal of Cancer 2003 105 5 674 680
22. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method Methods 2001 25 4 402 408
23. Baldini E., Camerini A., Sgambato A., Cyclin A and E2F1 overexpression correlate with reduced disease-free survival in node-negative breast cancer patients Anticancer Research 2006 26 6 4415 4421
24. Michalides R., van Tinteren H., Balkenende A., Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment British Journal of Cancer 2002 86 3 402 408
25. Poikonen P., Sjostrom J., Amini R.-M., Villman K., Ahlgren J., Blomqvist C., Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer British Journal of Cancer 2005 93 5 515 519
26. Engellau J., Bendahl P.-O., Persson A., Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays Human Pathology 2005 36 9 994 1002
27. Noguchi T., Dobashi Y., Minehara H., Itoman M., Kameya T., Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors American Journal of Pathology 2000 156 6 2135 2147
28. Nakamura N., Yamamoto H., Yao T., Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade Human Pathology 2005 36 7 828 837
29. Saarilahti K., Kajanti M., Kouri M., Aaltonen L.-M., Franssila K., Joensuu H., Cyclin A and Ki-67 expression as predictors for locoregional recurrence and outcome in laryngeal cancer patients treated with surgery and postoperative radiotherapy International Journal of Radiation Oncology Biology Physics 2003 57 4 986 995
30. Chen H.-M., Kuo M. Y.-P., Lin K.-H., Lin C.-Y., Chiang C.-P., Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan Oral Oncology 2003 39 5 476 482
31. Chao Y., Shih Y.-L., Chiu J.-H., Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma Cancer Research 1998 58 5 985 990
32. Molendini L., Benassi M. S., Magagnoli G., Prognostic significance of cyclin expression in human osteosarcoma International Journal of Oncology 1998 12 5 1007 1011
33. Nakabayashi H., Shimizu K., Hara M., Prognostic significance of cyclin A expression in meningiomas Applied Immunohistochemistry and Molecular Morphology 2003 11 1 9 14
34. Korshunov A., Shishkina L., Golanov A., DNA topoisomerase II- and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases Archives of Pathology and Laboratory Medicine 2002 126 9 1079 1086
35. Thomson P. J., Hamadah O., Goodson M. L., Cragg N., Booth C., Predicting recurrence after oral precancer treatment: use of cell cycle analysis British Journal of Oral Maxillofacial Surgery 2008 46 5 370 375
36. Bukholm I. R. K., Bukholm G., Nesland J. M., Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas International Journal of Cancer 2001 93 2 283 287
37. Huuhtanen R. L., Blomqvist C. P., Bohling T. O., Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness Cancer Research 1999 59 12 2885 2890
38. Zhou Q., He Q., Liang L.-J., Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance World Journal of Gastroenterology 2003 9 11 2450 2454
39. Mrena J., Wiksten J.-P., Kokkola A., Nordling S., Haglund C., Ristimaki A., Prognostic significance of cyclin A in gastric cancer International Journal of Cancer 2006 119 8 1897 1901
40. Blegen H., Will J. S., Ghadimi B. M., DNA amplifications and aneuploidy, high proliferative activity and impaired cell cycle control characterize breast carcinomas with poor prognosis Analytical Cellular Pathology 2003 25 3 103 114
41. Mattern J., Koomagi R., Volm M., Characteristics of long-term survivors of untreated lung cancer Lung Cancer 2002 36 3 277 282
42. Volm M., Koomagi R., Mattern J., Stammler G., Cyclin A is associated with an unfavourable outcome in patients with non-small cell lung carcinomas British Journal of Cancer 1997 75 12 1774 1778
43. Dobashi Y., Shoji M., Jiang S.-X., Kobayashi M., Kawakubo Y., Kameya T., Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas American Journal of Pathology 1998 153 3 963 972
44. Furihata M., Ishikawa T., Inoue A., Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma Clinical Cancer Research 1996 2 10 1781 1785
45. Wolowiec D., Berger F., Ffrench P., Bryon P. A., Ffrench M., CDK1 and cyclin A expression is linked to cell proliferation and associated with prognosis in non-Hodgkins lymphomas Leukemia Lymphoma 1999 35 1-2 147 157
46. Shih H.-C., Shiozawa T., Kato K., Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator Human Pathology 2003 34 5 471 478
47. Ekberg J., Holm C., Jalili S., Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcome European Journal of Haematology 2005 75 2 106 115
48. Furihata M., Ohtsuki Y., Sonobe H., Cyclin A overexpression in carcinoma of the renal pelvis and ureter including dysplasia: immunohistochemical findings in relation to prognosis Clinical Cancer Research 1997 3 8 1399 1404
49. Shiohara S., Shiozawa T., Miyamoto T., Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease Virchows Archiv 2005 446 6 626 633
50. Nilsson P. J., Lenander C., Rubio C., Auer G., Ljungqvist O., Glimelius B., Prognostic significance of cyclin A in epidermoid anal cancer Oncology Reports 2006 16 3 443 449
51. Bahnassy A. A., Zekri A.-R., El-Houssini S., Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients BMC Gastroenterology 2004 4, article 22
52. Handa K., Yamakawa M., Takeda H., Kimura S., Takahashi T., Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis International Journal of Cancer 1999 84 3 225 233
53. Nozoe T., Inutsuka S., Honda M., Ezaki T., Korenaga D., Clinicopathologic significance of cyclin A expression in colorectal carcinoma Journal of Experimental and Clinical Cancer Research 2004 23 1 127 133
54. Schuhmacher M., Staege M. S., Pajic A., Control of cell growth by c-Myc in the absence of cell division Current Biology 1999 9 21 1255 1258
55. Jansen-Durr P., Meichle A., Steiner P., Differential modulation of cyclin gene expression by MYC Proceedings of the National Academy of Sciences of the United States of America 1993 90 8 3685 3689
56. Buckley M. F., Sweeney K. J. E., Hamilton J. A., Expression and amplification of cyclin genes in human breast cancer Oncogene 1993 8 8 2127 2133
57. Khoo M. L. C., Ezzat S., Freeman J. L., Asa S. L., Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification Journal of Clinical Endocrinology Metabolism 2002 87 4 1810 1813
58. Platzer P., Upender M. B., Wilson K., Silence of chromosomal amplifications in colon cancer Cancer Research 2002 62 4 1134 1138
59. Nilbert M., Planck M., Fernebro E., Borg A., Johnson A., Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer European Journal of Cancer 1999 35 6 942 945
60. Fernebro E., Halvarsson B., Baldetorp B., Nilbert M., Predominance of CIN versus MSI in the development of rectal cancer at young age BMC Cancer 2002 2, article 25
61. Frattini M., Balestra D., Suardi S., Different genetic features associated with colon and rectal carcinogenesis Clinical Cancer Research 2004 10 12 4015 4021
62. Kapiteijn E., Liefers G. J., Los L. C., Mechanisms of oncogenesis in colon versus rectal cancer Journal of Pathology 2001 195 2 171 178